| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.14B | 34.37B | 31.89B | 30.33B | 27.30B | 24.48B |
| Gross Profit | 10.18B | 9.96B | 8.98B | 8.13B | 8.72B | 7.84B |
| EBITDA | 3.07B | 2.95B | 3.34B | 2.42B | 4.19B | 2.38B |
| Net Income | 943.00M | 1.01B | 1.28B | 615.00M | 1.81B | 518.00M |
Balance Sheet | ||||||
| Total Assets | 36.57B | 38.30B | 37.05B | 32.02B | 29.01B | 27.71B |
| Cash, Cash Equivalents and Short-Term Investments | 5.07B | 5.51B | 5.64B | 4.26B | 4.00B | 4.11B |
| Total Debt | 4.48B | 5.12B | 6.11B | 2.85B | 968.00M | 3.36B |
| Total Liabilities | 12.24B | 13.29B | 13.93B | 10.78B | 8.46B | 9.54B |
| Stockholders Equity | 21.14B | 21.68B | 20.13B | 18.53B | 17.96B | 15.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 217.00M | -828.00M | 1.37B | 1.60B |
| Operating Cash Flow | 0.00 | 2.75B | 2.93B | 515.00M | 2.33B | 2.09B |
| Investing Cash Flow | 0.00 | -1.21B | -4.25B | -1.17B | 603.00M | -660.00M |
| Financing Cash Flow | 0.00 | -1.68B | 2.82B | 1.23B | -2.94B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥19.55B | 14.61 | ― | 3.03% | 1.59% | -26.64% | |
79 Outperform | ¥25.47B | 6.38 | ― | 5.21% | 0.91% | 100.31% | |
71 Outperform | ¥23.97B | 10.51 | ― | 3.61% | 8.85% | 110.05% | |
69 Neutral | ¥15.95B | 9.49 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥16.85B | 13.84 | ― | 2.78% | 1.30% | -5.03% | |
66 Neutral | ¥26.07B | 13.86 | ― | 4.62% | 7.19% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |